Elevation Spine Achieves 5,000+ Saber-C® Implantations, Reaching a Major Clinical Milestone
Elevation Spine Surpasses 5,000 Saber-C Implantations, Highlighting Growing Adoption of Its Integrated Cervical Fusion Technology Elevation Spine has announced a significant milestone for its cervical spine portfolio, revealing that more…
Trodelvy® Wins U.S. FDA Approval for First-Line Metastatic Triple-Negative Breast Cancer
Trodelvy® is now FDA-approved as a first-line treatment option for patients with metastatic triple-negative breast cancer, expanding its role in frontline care. Gilead Sciences has secured a major new U.S.…
Carnegie Mellon Wins ARPA-H Contract to Advance Labor and Childbirth Care
Carnegie Mellon-Led Team Secures Up to $39.3 Million ARPA-H Award to Develop OMEGA Fetal Monitoring System Carnegie Mellon University is spearheading a major multi-institution research initiative aimed at transforming how…
TRYNGOLZA® Wins FDA Approval as First sHTG Treatment to Lower Triglycerides and Pancreatitis Risk
TRYNGOLZA® becomes the first and only FDA-approved treatment for severe hypertriglyceridemia, reducing both triglyceride levels and the risk of acute pancreatitis. Ionis Pharmaceuticals has secured a major regulatory milestone with…
Pfizer’s IBRANCE Wins FDA Approval for Frontline Maintenance in HR+, HER2+ Metastatic Breast Cancer
Pfizer’s IBRANCE Wins FDA Approval in HR+/HER2+ Metastatic Breast Cancer, Expanding CDK4/6 Use Into New Maintenance Setting Pfizer has secured a significant new U.S. regulatory milestone for IBRANCE (palbociclib), with…
AL-S Pharma Shares Phase 2 AP-101 Data at ENCALS 2026, Backing SOD1 as ALS Target
AL-S Pharma Presents Phase 2 AP-101 Data at ENCALS 2026, Highlighting Potential Disease-Modifying Effects in ALS AL-S Pharma AG, a clinical-stage biotechnology company focused on developing antibody therapies against misfolded…
AstraZeneca, YMCA Launch Landmark Partnership to Close Cancer Care Gaps
AstraZeneca and YMCA of the USA Launch Five-Year Partnership to Expand Cancer Screening, Early Detection and Survivorship Support Across the U.S. AstraZeneca and YMCA of the USA (Y-USA) have announced…
New Reproducibility Standard Set for Quantitative Biomarkers in Breast Imaging
New Reproducibility Standard Set for Breast Imaging Biomarkers QT Imaging Holdings, Inc., a medical device company focused on advancing breast health through radiation-free imaging technology, has reported new data characterizing…
EMD Serono Names New Leaders for Global Commercial Strategy and North America
EMD Serono Names Miguel Fernández Alcalde Head of Global Commercial Strategy, Appoints Monia Vial to Lead North America EMD Serono, the Healthcare business of Merck KGaA in the United States…
Anodyne Nanotech Raises $12.6M Series A to Advance Weekly GLP-1 Patch Into Phase I
Anodyne Nanotech Raises $12.6 Million Series A to Advance Weekly GLP-1 Patch for Obesity and Expand Transdermal Drug Delivery Platform Anodyne Nanotech Inc., a clinical-stage biotechnology company focused on transforming…
CEL-SCI, Saudi Amarox Sign Cancer Care Pact at BIO 2026
CEL-SCI and Saudi Amarox Formalize Partnership at BIO 2026 to Advance Oncology Innovation in Saudi Arabia CEL-SCI Corporation announced that it has officially completed a formal signing ceremony with Saudi…
Javelin Biotech and Pfizer Report Clinical PK Prediction Findings Using Multi-Tissue Chip Platform
Javelin Biotech Publishes Multi-Tissue Chip and PBPK Study Showing Potential to Predict Human Drug Pharmacokinetics Without Animal Data Javelin Biotech has announced the publication of a new scientific study that…